50 results
8-K
EX-99.1
8auxsr q7pbb6flpjt
12 Feb 24
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
4:00pm
8-K
EX-99.1
5kuobc93lbh5z0rx4n1h
9 Nov 23
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:44am
424B4
eplqa
2 Oct 23
Prospectus supplement with pricing info
5:05pm
8-K
EX-99.1
mt7pwb99 6jnlw89gjzg
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am
PRE 14A
04792h swk
21 Apr 23
Preliminary proxy
4:00pm